These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Prokinetics of gastrointestinal system; its newer aspects with regard to motillity stimulants]. Hongo M; Satake M Nihon Rinsho; 2002 Feb; 60 Suppl 2():382-8. PubMed ID: 11979811 [No Abstract] [Full Text] [Related]
4. [Effect of prokinetic drugs inhibiting dopaminergic system on gallbladder motility in subjects with duodenal ulcer]. Szabelska K; Chojnacki J; Grzegorczyk K; Mamos A Pol Merkur Lekarski; 1999 Apr; 6(34):188-91. PubMed ID: 10391057 [TBL] [Abstract][Full Text] [Related]
5. Gastroprokinetic effect of a new benzamide derivative itopride and its action mechanisms in conscious dogs. Iwanaga Y; Miyashita N; Saito T; Morikawa K; Itoh Z Jpn J Pharmacol; 1996 Jun; 71(2):129-37. PubMed ID: 8835639 [TBL] [Abstract][Full Text] [Related]
6. A comparative study on the effects of domperidone, metoclopramide, clebopride and trimebutine on the gastro-duodenal preparation of the guinea pig. Schuurkes JA; Helsen LF; Van Nueten JM Jpn J Pharmacol; 1985 Oct; 39(2):123-30. PubMed ID: 4087563 [TBL] [Abstract][Full Text] [Related]
7. Effects of exepanol-HCl, metoclopramide and domperidone on the lower esophageal sphincter of dogs. Wolf KU Arzneimittelforschung; 1985; 35(1):136-7. PubMed ID: 4039143 [TBL] [Abstract][Full Text] [Related]
8. [Comparative study on the effect of the dopamine receptor blockers metoclopramide and domperidone on stomach emptying and the visualization of the small intestine in monocontrast]. Stellamor K; Hruby W Wien Klin Wochenschr; 1983 Sep; 95(18):649-52. PubMed ID: 6649651 [TBL] [Abstract][Full Text] [Related]
9. Review of the current status of prokinetic agents in gastroenterology. McCallum RW Am J Gastroenterol; 1985 Dec; 80(12):1008-16. PubMed ID: 4072997 [No Abstract] [Full Text] [Related]
10. AS-4370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties. Yoshida N; Omoya H; Oka M; Furukawa K; Ito T; Karasawa T Arch Int Pharmacodyn Ther; 1989; 300():51-67. PubMed ID: 2533479 [TBL] [Abstract][Full Text] [Related]
11. Control of gastroduodenal coordination: dopaminergic and cholinergic pathways. Schuurkes JA; Van Nueten JM Scand J Gastroenterol Suppl; 1984; 92():8-12. PubMed ID: 6146199 [TBL] [Abstract][Full Text] [Related]
12. Domperidone improves myogenically transmitted antroduodenal coordination by blocking dopaminergic receptor sites. Schuurkes JA; Van Nueten JM Scand J Gastroenterol Suppl; 1984; 96():101-10. PubMed ID: 6147889 [TBL] [Abstract][Full Text] [Related]
13. L-646,462, a cyproheptadine-related antagonist of dopamine and serotonin with selectivity for peripheral systems. Williams M; Martin GE; Remy DC; Hichens M; Mangel AW; Taylor DA; Yarbrough GG; Bendesky RJ; King SW; Robinson JL J Pharmacol Exp Ther; 1984 Jun; 229(3):775-81. PubMed ID: 6547178 [TBL] [Abstract][Full Text] [Related]
14. Role of dopamine receptors in gastrointestinal motility. Dhasmana KM; Banerjee AK; Zhu YN; Erdmann W; Parmar SS; Salzman SK Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):485-8. PubMed ID: 2571179 [TBL] [Abstract][Full Text] [Related]
15. [Comparative study of effects of gastrointestinal-motility control agents on rats and human colon]. Sasaki D; Kawakami S; Yoshida Y Nihon Heikatsukin Gakkai Zasshi; 1990 Apr; 26(2):85-8. PubMed ID: 2273693 [No Abstract] [Full Text] [Related]
16. [Effect of dopamine and its antagonists on contractile activity of the lower esophageal sphincter and the stomach (author's transl)]. Itoh Z; Aizawa I; Nakamura T Nihon Heikatsukin Gakkai Zasshi; 1980 Jun; 16(2):99-107. PubMed ID: 7265602 [TBL] [Abstract][Full Text] [Related]
17. Antagonism of cisplatin-induced emesis by metoclopramide and dazopride through enhancement of gastric motility. Alphin RS; Proakis AG; Leonard CA; Smith WL; Dannenburg WN; Kinnier WJ; Johnson DN; Sancilio LF; Ward JW Dig Dis Sci; 1986 May; 31(5):524-9. PubMed ID: 3698769 [TBL] [Abstract][Full Text] [Related]
18. Stimulatory effect of N-[4-[2-(dimethylamino)-ethoxy] benzyl]-3,4-dimethoxybenzamide hydrochloride (HSR-803) on normal and delayed gastrointestinal propulsion. Iwanaga Y; Miyashita N; Mizutani F; Morikawa K; Kato H; Ito Y; Itoh Z Jpn J Pharmacol; 1991 Jul; 56(3):261-9. PubMed ID: 1895573 [TBL] [Abstract][Full Text] [Related]